Capital Fund Management (CFM)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-19,838
| Closed | -$1.79M | – | 2727 |
|
|
2025
Q2 | $1.65M | Sell |
19,838
-166,055
| -89% | -$13.2M | ﹤0.01% | 1779 |
|
|
2025
Q1 | $15.1M | Buy |
+185,893
| New | +$16.6M | 0.04% | 533 |
|
|
2024
Q1 | – | Sell |
-349,708
| Closed | -$32.5M | – | 2315 |
|
|
2023
Q4 | $31.2M | Sell |
349,708
-308,386
| -47% | -$22.9M | 0.08% | 317 |
|
|
2023
Q3 | $48.1M | Buy |
658,094
+296,705
| +82% | +$23.7M | 0.17% | 155 |
|
|
2023
Q2 | $30.1M | Buy |
361,389
+89,714
| +33% | +$7.5M | 0.12% | 218 |
|
|
2023
Q1 | $20.7M | Buy |
271,675
+230,942
| +567% | +$19.2M | 0.1% | 268 |
|
|
2022
Q4 | $3.38M | Buy |
+40,733
| New | +$3.3M | 0.02% | 771 |
|
|
2022
Q1 | – | Sell |
-42,636
| Closed | -$3.94M | – | 1840 |
|
|
2021
Q4 | $4.77M | Buy |
42,636
+7,167
| +20% | +$864K | 0.03% | 657 |
|
|
2021
Q3 | $4.46M | Sell |
35,469
-23,732
| -40% | -$3.06M | 0.03% | 624 |
|
|
2021
Q2 | $8.02M | Buy |
59,201
+10,076
| +21% | +$1.32M | 0.06% | 395 |
|
|
2021
Q1 | $6.66M | Buy |
49,125
+24,766
| +102% | +$3.71M | 0.07% | 326 |
|
|
2020
Q4 | $3.43M | Buy |
24,359
+5,488
| +29% | +$703K | 0.03% | 599 |
|
|
2020
Q3 | $2.1M | Buy |
+18,871
| New | +$2.12M | 0.03% | 620 |
|
|
2020
Q2 | – | Sell |
-18,298
| Closed | -$1.8M | – | 1634 |
|
|
2020
Q1 | $1.42M | Sell |
18,298
-57,875
| -76% | -$5.12M | 0.02% | 636 |
|
|
2019
Q4 | $7.25M | Buy |
+76,173
| New | +$6.59M | 0.06% | 433 |
|
|
2019
Q3 | – | Sell |
-18,502
| Closed | -$1.54M | – | 1928 |
|
|
2019
Q2 | $1.62M | Sell |
18,502
-6,945
| -27% | -$592K | 0.01% | 860 |
|
|
2019
Q1 | $2.3M | Sell |
25,447
-22,987
| -47% | -$1.96M | 0.02% | 756 |
|
|
2018
Q4 | $3.48M | Buy |
+48,434
| New | +$3.9M | 0.03% | 633 |
|
|
2018
Q3 | – | Sell |
-46,510
| Closed | -$4.43M | – | 2317 |
|
|
2018
Q2 | $4.43M | Buy |
+46,510
| New | +$4.27M | 0.02% | 780 |
|
|
2018
Q1 | – | Sell |
-29,459
| Closed | -$2.69M | – | 2222 |
|
|
2017
Q4 | $2.5M | Buy |
+29,459
| New | +$2.47M | 0.01% | 902 |
|
|
2017
Q3 | – | Sell |
-59,260
| Closed | -$4.75M | – | 1777 |
|
|
2017
Q2 | $4.57M | Buy |
+59,260
| New | +$4.2M | 0.04% | 495 |
|
|
2017
Q1 | – | Sell |
-68,790
| Closed | -$4.07M | – | 1874 |
|
|
2016
Q4 | $4.07M | Buy |
68,790
+13,912
| +25% | +$859K | 0.04% | 554 |
|
|
2016
Q3 | $3.64M | Buy |
+54,878
| New | +$3.39M | 0.03% | 561 |
|
|
2016
Q1 | – | Sell |
-54,558
| Closed | -$2.83M | – | 1899 |
|
|
2015
Q4 | $3.82M | Sell |
54,558
-53,200
| -49% | -$3.63M | 0.04% | 516 |
|
|
2015
Q3 | $6.71M | Buy |
107,758
+96,640
| +869% | +$7.62M | 0.08% | 332 |
|
|
2015
Q2 | $935K | Sell |
11,118
-22,677
| -67% | -$1.76M | 0.01% | 853 |
|
|
2015
Q1 | $2.54M | Sell |
33,795
-16,230
| -32% | -$1.13M | 0.03% | 525 |
|
|
2014
Q4 | $3.11M | Buy |
50,025
+13,425
| +37% | +$765K | 0.04% | 564 |
|
|
2014
Q3 | $1.9M | Sell |
36,600
-22,899
| -38% | -$1.17M | 0.02% | 696 |
|
|
2014
Q2 | $3.06M | Buy |
+59,499
| New | +$2.68M | 0.03% | 583 |
|
Other funds holding XBI
Capital Fund Management (CFM)'s XBI Position: Q3 2025 in Review
Capital Fund Management (CFM) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 19,838 shares — an estimated $1.79M sold.
Capital Fund Management (CFM) first reported a position in XBI in Q2 2014 and held it in 30 quarters. The position peaked at $48.1M in Q3 2023. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.
- Capital Fund Management (CFM) reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
- Capital Fund Management (CFM) sold 19,838 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.79M.
- Capital Fund Management (CFM) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and held it in 30 quarters.
- Capital Fund Management (CFM)'s State Street SPDR S&P Biotech ETF position peaked at $48.1M in Q3 2023.
- 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.
Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.